MARATTO

article · Egyptian Journal of Psychiatry

A Study of Psychiatric Comorbidities in a Sample of Egyptian Patients with End-Stage Renal Disease on Hemodialysis

20241 citationBenha University

Abstract

BackgroundChronic renal failure is considered a major world health problem and in Egypt as well.ObjectivesTo assess psychiatric comorbidities in patients with end-stage renal disease (ESRD) and the effect of ESRD on patient’s quality of life (QOL).Patients and MethodsA total of 140 patients undergoing hemodialysis treatment in the hemodialysis unit of Benha University Hospital were chosen by nonrandom technique, and a descriptive cross-sectional study was conducted using a semi-structured interview, clinical psychiatric assessment, psychometric test measuring psychiatric disease [Structured Clinical Interview for Diagnostic and Statistical Manual of Mental Disorders-4th ed. (DSM-IV) axis I Disorders], and psychometric test measuring QOL.ResultsThe study revealed that more than half of the studied sample experienced psychiatric illness (82.1%), including depression and anxiety. Depression was the most common psychiatric illness detected among the studied group (67.1%) followed by generalized anxiety disorder (53.6%) and panic attacks (8.6%). The total QOL score was affected by 59.2% in patients with ESRD with psychiatric illness.ConclusionsThere is high incidence of psychiatric disorders among patients with ESRD, with depression and anxiety disorders being the most prevalent disorders and that adversely affect QOL observed in patients with ESRD.

Research topics

  • Health and Well-being Studies

Read the original research

This page summarises published work. The authoritative version sits with the publisher.

DOI: 10.21608/ejpsy.2024.380498

Is something wrong with this record? Report it or request removal.

Discussion

Discuss this research

Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.

No discussion yet. Open the first thread.